Kidney disease in children: Latest advances and remaining challenges

Nature Reviews Nephrology

Volumn 12, Issue 3, 2016, Pages 182-191

  Bertram, John F ^a   Goldstein, Stuart L ^b   Pape, Lars ^c   Schaefer, Franz ^d   Shroff, Rukshana C ^e   Warady, Bradley A ^f  

^a MONASH UNIVERSITY   (Australia)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DONOR SPECIFIC ANTIBODY; EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; SOMATOMEDIN; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; BLOOD VESSEL CALCIFICATION; BONE DISEASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CHILD; CHILD GROWTH; CHILDHOOD DISEASE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; DEVELOPMENTAL BIOLOGY; DISEASE ASSOCIATION; EPITHELIAL MESENCHYMAL TRANSITION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DISORDER; GRAFT FAILURE; GRAFT RECIPIENT; GROWTH DISORDER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DEVELOPMENT; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LONG TERM CARE; NEPHROTOXICITY; NUTRITIONAL HEALTH; PRENATAL CARE; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SHORT COURSE THERAPY; SUBSTITUTION THERAPY; TRANSITION TO ADULT CARE; ADOLESCENT; ADULT; INFANT; KIDNEY DISEASES; NEWBORN; PRESCHOOL CHILD; RENAL REPLACEMENT THERAPY; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; RENAL DIALYSIS; YOUNG ADULT;

EID: 84958871491     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2015.219     Document Type: Review

References (84)

1. Little, M. H. Kidney Development, Disease, Repair and Regeneration (Elsevier Academic Press, 2016
2. Park, J. S., & McMahon, A. P. in Kidney Development, Disease, Repair and Regeneration (ed Little, M. H.) 67-74 (Elsevier Academic Press, 2016
3. Bertram, J. F., Douglas-Denton, R. N., Diouf, B., Hughson, M. D., & Hoy, W. E. Human nephron number: implications for health and disease. Pediatr. Nephrol. 26, 1529-1533 (2011
4. Zhang, Z., et al. A common RET variant is associated with reduced newborn kidney size and function. J. Am. Soc. Nephrol. 19, 2027-2034 (2008
5. Hughson, M., Farris, A. B. 3rd, Douglas-Denton, R., Hoy, W. E., & Bertram J. F. Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int. 63, 2113-2122 (2003
6. Costantini, F. in Kidney Development, Disease, Repair and Regeneration (ed Little, M. H.) 41-56 (Elsevier Academic Press, 2016
7. Oxburgh, L. in Kidney Development, Disease, Repair and Regeneration (ed Little, M. H.) 75-86 (Elsevier Academic Press, 2016
8. Park, J. S., & Kopan, R. in Kidney Development, Disease, Repair and Regeneration (ed Little, M. H.) 87-93 (Elsevier Academic Press, 2016
9. McMahon, A. P., et al. GUDMAP: the genitourinary developmental molecular anatomy project. J. Am. Soc. Nephrol. 19, 667-671 (2008
10. Harding, S. D., et al. The GUDMAP database-An online resource for genitourinary research. Development 138, 2845-2853 (2011
11. Luyckx, V. A., et al. Effect of fetal and child health on kidney development and long-Term risk of hypertension and kidney disease. Lancet 382, 273-283 (2013
12. Moritz, K. M. in Kidney Development, Disease, Repair and Regeneration (ed Little, M. H.) 177-190 (Elsevier Academic Press, 2016
13. Nicolaou, N., Renkema, K. Y., Bongers, E. M., Giles, R. H., & Knoers, N. V. Genetic, environmental, and epigenetic factors involved in CAKUT. Nat. Rev. Nephrol. 11, 720-731 (2015
14. Beeman, S. C., et al. MRI-based glomerular morphology and pathology in whole human kidneys. Am. J. Physiol. Renal 306, F1381-F1390 (2014
15. Sutherland, M. R., et al. Accelerated maturation and abnormal morphology in the preterm neonatal kidney. J. Am. Soc. Nephrol. 22, 1365-1374 (2011
16. Sutherland, S. M., et al. AKI in hospitalized children: epidemiology and clinical associations in a national cohort. Clin. J. Am. Soc. Nephrol. 8, 1661-1669 (2013
17. Sanchez-Pinto, L. N., Goldstein, S. L., Schneider, J. B., & Khemani, R. G. Association between progression and improvement of acute kidney injury and mortality in critically ill children. Pediatr. Crit. Care Med. 16, 703-710 (2015
18. Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO clinical practice guideline for acute kidney injury. Kidney Int. Suppl. 2, 1-138 (2012
19. Kellum, J. A., Bellomo, R., & Ronco, C. Kidney attack. JAMA 307, 2265-2266 (2012
20. Goldstein, S. L., & Chawla, L. S. Renal angina. Clin. J. Am. Soc. Nephrol. 5, 943-949 (2010
21. Basu, R. K., et al. Derivation and validation of the renal angina index to improve the prediction of acute kidney injury in critically ill children. Kidney Int. 85, 659-667 (2014
22. Basu, R. K., et al. Incorporation of biomarkers with the renal angina index for prediction of severe AKI in critically ill children. Clin. J. Am. Soc. Nephrol. 9, 654-662 (2014
23. Basu, R. K., et al. Assessment of Worldwide Acute Kidney Injury, Renal Angina and Epidemiology in critically ill children (AWARE): study protocol for a prospective observational study. BMC Nephrol. 16, 24 (2015
24. Hui-Stickle, S., Brewer, E. D., & Goldstein, S. L. Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am. J. Kidney Dis. 45, 96-101 (2005
25. Zappitelli, M., Moffett, B. S., Hyder, A., & Goldstein, S. L. Acute kidney injury in non-critically ill children treated with aminoglycoside antibiotics in a tertiary healthcare centre: a retrospective cohort study. Nephrol. Dial. Transplant. 26, 144-150 (2011
26. Goldstein, S. L., et al. Electronic health record identification of nephrotoxin exposure and associated acute kidney injury. Pediatrics 132, e756-e767 (2013
27. Askenazi, D. J., Ambalavanan, N., & Goldstein, S. L. Acute kidney injury in critically ill newborns: what do we know? What do we need to learn? Pediatr. Nephrol. 24, 265-274 (2009
28. White, S. L., et al. Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. Am. J. Kidney Dis. 54, 248-261 (2009
29. Ronco, C., et al. Continuous renal replacement therapy in neonates and small infants: development and first in human use of a miniaturised machine (CARPEDIEM). Lancet 383, 1807-1813 (2014
30. Coulthard, M. G., et al. Haemodialysing babies weighing kg with the Newcastle infant dialysis and ultrafiltration system (Nidus): comparison with peritoneal and conventional haemodialysis Pediatr. Nephrol 29 1873-1881 2014
31. Frei, U., & Schober-Halstenberg, H.-J. Nierenersatztherapie in Deutschland. Bericht über Dialysebehandlung und Nierentransplantation in Deutschland. Bundesverband Niere E.V. [online], http://www.bundesverband-niere.de/fileadmin/user- upload/QuaSi-Niere-Bericht-2006-2007.pdf (2008
32. Foster, B. J. Heightened graft failure risk during emerging adulthood and transition to adult care. Pediatr. Nephrol. 30, 567-576 (2015
33. Foster, B. J., et al. Association between age and graft failure rates in young kidney transplant recipients. Transplantation 92, 1237-1243 (2011
34. Watson, A. R. Non-compliance and transfer from paediatric to adult transplant unit. Pediatr. Nephrol. 14, 469-472 (2000
35. Prestidge, C., Romann, A., Djurdjev, O., & Matsuda-Abedini, M. Utility and cost of a renal transplant transition clinic. Pediatr. Nephrol. 27, 295-302 (2012
36. Harden, P. N., et al. Bridging the gap: an integrated paediatric to adult clinical service for young adults with kidney failure. BMJ 344, e3718 (2012
37. Kreuzer, M., et al. The TRANSNephro-study examining a new transition model for post-kidney transplant adolescents and an analysis of the present health care: study protocol for a randomized controlled trial. Trials 15, 505 (2014
38. Brunkhorst, L. C., et al. Efficacy and safety of an everolimus-versus a mycophenolate mofetil-based regimen in pediatric renal transplant recipients. PLoS ONE 10, e0135439 (2015
39. Ahlenstiel-Grunow, T., et al. A multicenter, randomized, open-labeled study to steer immunosuppressive and antiviral therapy by measurement of virus (CMV, ADV, HSV)-specific T cells in addition to determination of trough levels of immunosuppressants in pediatric kidney allograft recipients (IVIST01 trial): study protocol for a randomized controlled trial. Trials 15, 324 (2014
40. Miettinen, J., et al. Donor-specific HLA antibodies and graft function in children after renal transplantation. Pediatr. Nephrol. 27, 1011-1019 (2012
41. Einecke, G., et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am. J. Transplant. 9, 2520-2531 (2009
42. Billing, H., et al. Successful treatment of chronic antibody-mediated rejection with IVIG and rituximab in pediatric renal transplant recipients. Transplantation 86, 1214-1221 (2008
43. Hartmann, H., et al. Early kidney transplantation improves neurocognitive outcome in patients with severe congenital chronic kidney disease. Transpl. Int. 28, 429-436 (2015
44. Offner, G., et al. Kidney transplanted children come of age. Kidney Int. 55, 1509-1517 (1999
45. Devuyst, O., Knoers, N. V., Remuzzi, G., & Schaefer, F. Rare inherited kidney diseases: challenges, opportunities, and perspectives. Lancet 383, 1844-1859 (2014
46. Sadowski, C. E., et al. A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J. Am. Soc. Nephrol. 26, 1279-1289 (2015
47. Lipska, B. S., et al. Genotype-phenotype associations in WT1 glomerulopathy. Kidney Int. 85, 1169-1178 (2014
48. Cramer, M. T., et al. Expanding the phenotype of proteinuria in Dent disease. A case series. Pediatr. Nephrol. 29, 2051-2054 (2014
49. Weber, S., et al. Prevalence of mutations in renal developmental genes in children with renal hypodysplasia: results of the ESCAPE study. J. Am. Soc. Nephrol. 17, 2864-2870 (2006
50. Bockenhauer, D., & Jaureguiberry, G. HNF1B associated clinical phenotypes: the kidney and beyond. Pediatr Nephrol. http://dx.doi.org/10.1007/s00467-015-3142-2 (2015
51. Wong, E. K., Goodship, T. H., & Kavanagh, D. Complement therapy in atypical haemolytic uraemic syndrome (aHUS). Mol. Immunol. 56, 199-212 (2013
52. Heeringa, S. F., et al. COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J. Clin. Invest. 121, 2013-2024 (2011
53. Korkmaz, E., et al. ADCK4 associated glomerulopathy causes adolescence-onset FSGS. J. Am. Soc. Nephrol. 27, 63-68 (2015
54. Nicolaou, N., Renkema, K. Y., Bongers, E. M., Giles, R. H., & Knoers, N. V. Genetic, environmental, and epigenetic factors involved in CAKUT. Nat. Rev. Nephrol. 11, 11720-11731 (2015
55. Dart, A. B., Ruth, C. A., Sellers, E. A., Au, W., & Dean, H. J. Maternal diabetes mellitus and congenital anomalies of the kidney and urinary tract (CAKUT) in the child. Am. J. Kidney Dis. 65, 684-691 (2015
56. USRDS. USRDS 2011 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. [online], http://www.usrds.org/2011/view/v1-00a-intro.asp (2011
57. Borzych, D., et al. The bone and mineral disorder of children undergoing chronic peritoneal dialysis. Kidney Int. 78, 1295-1304 (2010
58. Shroff, R., Long, D. A., & Shanahan, C. Mechanistic insights into vascular calcification in CKD. J. Am. Soc. Nephrol. 24, 179-189 (2013
59. Shroff, R., et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 118, 1748-1757 (2008
60. Ragnauth, C. D., et al. Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging. Circulation 121, 2200-2210 (2010
61. Goodman, W. G., et al. Coronary-Artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N. Engl. J. Med. 342, 1478-1483 (2000
62. J. Oh et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106, 100-105 (2002
63. Brady, T. M., et al. Carotid intima-media thickness in children with CKD: results from the CKiD study. Clin. J. Am. Soc. Nephrol. 7, 1930-1937 (2012
64. Kupferman, J. C., et al. BP control and left ventricular hypertrophy regression in children with CKD. J. Am. Soc. Nephrol. 25, 167-174 (2014
65. Khouzam, N. M., Wesseling-Perry, K., & Salusky, I. B. The role of bone in CKD-mediated mineral and vascular disease. Pediatr. Nephrol. 30, 1379-1388 (2015
66. Denburg, M. R., et al. Fracture burden and risk factors in childhood CKD: results from the CKiD Cohort Study. J. Am. Soc. Nephrol. http://dx.doi.org/10.1681/ASN.2015020152 (2015
67. Salusky, B., et al. Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols. J. Am. Soc. Nephrol. 16, 2501-2508 (2005
68. KDIGO. Clinical practice guideline for the diagnosis KDIGO evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int. 76 (Suppl. 113), S1 (2009
69. Hahn, D., & Hodson, E. M., & Craig, J. C. Interventions for metabolic bone disease in children with chronic kidney disease. Cochrane Database Syst. Rev. 11, CD008327 (2015
70. Querfeld, U., et al. The Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study: objectives, design, and methodology. Clin. J. Am. Soc. Nephrol. 5, 1642-1648 (2010
71. Guthrie, L. G. Chronic interstitial nephritis in childhood. Lancet 149, 585 (1897
72. Furth, S. L., Stablein, D., Fine R. N., Powe, N. R., & Fivush, B. A. Adverse clinical outcomes associated with short stature at dialysis initiation: a report of the North American Pediatric Renal Transplant Cooperative study. Pediatrics 109, 909-913 (2002
73. Rosenkranz, J., et al. Psychosocial rehabilitation and satisfaction with life in adults with childhood-onset of end-stage renal disease. Pediatr. Nephrol. 20, 1288-1294 (2005
74. Martz, K., & Stablein, D. M. North American Pediatric Renal Trials and Cooperative Studies (NAPRTCS) 2008 annual report. Emmes [online], https://web.emmes.com/study/ped/annlrept/Annual%20Report%20-2008.pdf (2008
75. Rodig, N. M., et al. Growth in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children Study. Pediatr. Nephrol. 29, 1987-1995 (2014
76. North American Pediatric Renal Trials and Cooperative Studies (NAPRTCS) 2011 annual dialysis report. Emmes [online], https://web.emmes.com/study/ped/annlrept/annualrept2011.pdf (2011
77. North American Pediatric Renal Trials and Cooperative Studies (NAPRTCS) 2014 annual transplant report. Emmes [online], https://web.emmes.com/study/ped/annlrept/annualrept2014.pdf (2014
78. Karlberg, J., et al. Early age-dependent growth impairment in chronic renal failure. Pediatr. Nephrol. 10, 283-287 (1996
79. NKF-KDOQI clinical practice guideline for nutrition in children with CKD. Am. J. Kidney Dis. 53 (Suppl. 2), S1-S124 (2009
80. Wong, C. S., et al. Anthropometric measures and risk of death in children with end-stage renal disease. Am. J. Kidney Dis. 36, 811-819 (2000
81. Mak, R. H., Cheung, W. W., & Roberts, C. T. Jr. The growth hormone-insulin-like growth factor I axis in chronic kidney disease. Growth Horm. IGF Res. 18, 17-25 (2008
82. Mehls, O., et al. Long-Term growth hormone treatment in short children with CKD does not accelerate decline of renal function: results from the KIGS registry & ESCAPE trial. Pediatr. Nephrol. 30, 2145-2151 (2015
83. Fischbach, M., et al. Daily online haemodiafiltration promotes catch-up growth in children on chronic dialysis. Nephrol Dial. Transplant. 25, 867-873 (2010
84. Watson, A. R., et al. Transition from pediatric to adult renal services: a consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA). Pediatr. Nephrol. 26, 1753-1757 (2011